Phibro Animal Health Corporation (NASDAQ:PAHC) Given Consensus Rating of "Reduce" by Brokerages

Shares of Phibro Animal Health Corporation (NASDAQ:PAHC - Get Free Report) have been given a consensus rating of "Reduce" by the six analysts that are currently covering the stock, MarketBeat Ratings reports. Two investment analysts have rated the stock with a sell recommendation, three have issued a hold recommendation and one has issued a buy recommendation on the company. The average 12 month price objective among brokerages that have issued a report on the stock in the last year is $24.40.

A number of research firms recently issued reports on PAHC. BNP Paribas Exane upgraded Phibro Animal Health from an "underperform" rating to a "neutral" rating and set a $24.00 price objective for the company in a research report on Monday, June 16th. BNP Paribas upgraded Phibro Animal Health to a "hold" rating in a research report on Monday, June 16th. Wall Street Zen upgraded Phibro Animal Health from a "hold" rating to a "buy" rating in a research report on Friday, May 9th. JPMorgan Chase & Co. upgraded Phibro Animal Health from a "neutral" rating to an "overweight" rating and upped their price objective for the company from $25.00 to $35.00 in a report on Monday, July 7th. Finally, Morgan Stanley set a $26.00 price target on Phibro Animal Health and gave the stock an "equal weight" rating in a report on Wednesday, June 25th.

Hedge Funds Weigh In On Phibro Animal Health

Several hedge funds and other institutional investors have recently modified their holdings of PAHC. Nuveen LLC bought a new position in shares of Phibro Animal Health in the 1st quarter valued at $10,312,000. Invesco Ltd. increased its stake in shares of Phibro Animal Health by 92.3% in the 1st quarter. Invesco Ltd. now owns 387,739 shares of the company's stock valued at $8,282,000 after purchasing an additional 186,087 shares during the last quarter. Axecap Investments LLC bought a new position in shares of Phibro Animal Health in the 1st quarter valued at $3,696,000. Millennium Management LLC increased its stake in shares of Phibro Animal Health by 74.3% in the 1st quarter. Millennium Management LLC now owns 362,030 shares of the company's stock valued at $7,733,000 after purchasing an additional 154,281 shares during the last quarter. Finally, Jacobs Levy Equity Management Inc. increased its stake in shares of Phibro Animal Health by 56.7% in the 4th quarter. Jacobs Levy Equity Management Inc. now owns 301,173 shares of the company's stock valued at $6,325,000 after purchasing an additional 108,918 shares during the last quarter. Institutional investors own 99.34% of the company's stock.

Phibro Animal Health Stock Performance

Shares of NASDAQ:PAHC opened at $27.14 on Tuesday. The company has a market cap of $1.10 billion, a P/E ratio of 34.80, a PEG ratio of 0.44 and a beta of 0.80. The company has a debt-to-equity ratio of 2.67, a quick ratio of 1.23 and a current ratio of 2.91. Phibro Animal Health has a one year low of $16.16 and a one year high of $31.80. The business's 50-day simple moving average is $26.70 and its 200 day simple moving average is $23.32.

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last posted its quarterly earnings data on Wednesday, May 7th. The company reported $0.63 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.52 by $0.11. The company had revenue of $347.80 million for the quarter, compared to the consensus estimate of $352.41 million. Phibro Animal Health had a return on equity of 30.51% and a net margin of 2.68%. On average, sell-side analysts forecast that Phibro Animal Health will post 1.95 earnings per share for the current fiscal year.

Phibro Animal Health Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 24th. Stockholders of record on Wednesday, September 3rd will be paid a $0.12 dividend. The ex-dividend date is Wednesday, September 3rd. This represents a $0.48 annualized dividend and a dividend yield of 1.8%. Phibro Animal Health's dividend payout ratio (DPR) is presently 61.54%.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.